p.122 抽出テキスト

American Heart Association and American College of Cardiology. J Am Coll Cardiol 2015;66:2444–2446. https://doi.org/10.1016/j.jacc.2015.09.046 1099. Reineck E, Rolston B, Bragg-Gresham JL, Salberg L, Baty L, Kumar S, et al. Physical activity and other health behaviors in adults with hypertrophic cardiomyopathy. Am J Cardiol 2013;111:1034–1039. https://doi.org/10.1016/j.amjcard.2012.12.018 1100. Sweeting J, Ingles J, Timperio A, Patterson J, Ball K, Semsarian C. Physical activity in hypertrophic cardiomyopathy: prevalence of inactivity and perceived barriers. Open Heart 2016;3:e000484. https://doi.org/10.1136/openhrt-2016-000484 1101. Olivotto I, Maron BJ, Tomberli B, Appelbaum E, Salton C, Haas TS, et al. Obesity and its association to phenotype and clinical course in hypertrophic cardiomyopathy. J Am Coll Cardiol 2013;62:449–457. https://doi.org/10.1016/j.jacc.2013.03.062 1102. Fumagalli C, Maurizi N, Day SM, Ashley EA, Michels M, Colan SD, et al. Association of obesity with adverse long-term outcomes in hypertrophic cardiomyopathy. JAMA Cardiol 2020;5:65–72. https://doi.org/10.1001/jamacardio.2019.4268 1103. Pelliccia A, Fagard R, Bjornstad HH, Anastassakis A, Arbustini E, Assanelli D, et al. Recommendations for competitive sports participation in athletes with cardiovascular disease: a consensus document from the Study Group of Sports Cardiology of the Working Group of Cardiac Rehabilitation and Exercise Physiology and the Working Group of Myocardial and Pericardial Diseases of the European Society of Cardiology. Eur Heart J 2005;26:1422–1445. https://doi.org/10.1093/eurheartj/ehi325 1104. Sorajja P, Allison T, Hayes C, Nishimura RA, Lam CS, Ommen SR. Prognostic utility of metabolic exercise testing in minimally symptomatic patients with obstructive hypertrophic cardiomyopathy. Am J Cardiol 2012;109:1494–1498. https://doi.org/10.1016/j. amjcard.2012.01.363 1105. Desai MY, Bhonsale A, Patel P, Naji P, Smedira NG, Thamilarasan M, et al. Exercise echocardiography in asymptomatic HCM: exercise capacity, and not LV outflow tract gradient predicts long-term outcomes. JACC Cardiovasc Imaging 2014;7:26–36. https:// doi.org/10.1016/j.jcmg.2013.08.010 1106. Konhilas JP, Watson PA, Maass A, Boucek DM, Horn T, Stauffer BL, et al. Exercise can prevent and reverse the severity of hypertrophic cardiomyopathy. Circ Res 2006;98: 540–548. https://doi.org/10.1161/01.RES.0000205766.97556.00 1107. Pelliccia A, Borrazzo C, Caselli S, Lemme E, Musumeci MB, Maestrini V, et al. Neither athletic training nor detraining affects LV hypertrophy in adult, low-risk patients with HCM. JACC Cardiovasc Imaging 2022;15:170–171. https://doi.org/10.1016/j.jcmg. 2021.08.012 1108. Klempfner R, Kamerman T, Schwammenthal E, Nahshon A, Hay I, Goldenberg I, et al. Efficacy of exercise training in symptomatic patients with hypertrophic cardiomyopathy: results of a structured exercise training program in a cardiac rehabilitation center. Eur J Prev Cardiol 2015;22:13–19. https://doi.org/10.1177/2047487313501277 1109. Kwon S, Lee H-J, Han K-D, Kim DH, Lee S-P, Hwang I-C, et al. Association of physical activity with all-cause and cardiovascular mortality in 7666 adults with hypertrophic cardiomyopathy (HCM): more physical activity is better. Br J Sports Med 2021;55: 1034–1040. https://doi.org/10.1136/bjsports-2020-101987 1110. Benito B, Gay-Jordi G, Serrano-Mollar A, Guasch E, Shi Y, Tardif J-C, et al. Cardiac arrhythmogenic remodeling in a rat model of long-term intensive exercise training. Circulation 2011;123:13–22. https://doi.org/10.1161/CIRCULATIONAHA.110. 938282 1111. Saberniak J, Hasselberg NE, Borgquist R, Platonov PG, Sarvari SI, Smith H-J, et al. Vigorous physical activity impairs myocardial function in patients with arrhythmogenic right ventricular cardiomyopathy and in mutation positive family members. Eur J Heart Fail 2014;16:1337–1344. https://doi.org/10.1002/ejhf.181 1112. Ruwald AC, Marcus F, Estes NA, Link M, McNitt S, Polonsky B, et al. Association of competitive and recreational sport participation with cardiac events in patients with arrhythmogenic right ventricular cardiomyopathy: results from the North American multidisciplinary study of arrhythmogenic right ventricular cardiomyopathy. Eur Heart J 2015;36:1735–1743. https://doi.org/10.1093/eurheartj/ehv110 1113. Lampert R, Olshansky B, Heidbuchel H, Lawless C, Saarel E, Ackerman M, et al. Safety of sports for athletes with implantable cardioverter-defibrillators: long-term results of a prospective multinational registry. Circulation 2017;135:2310–2312. https://doi. org/10.1161/CIRCULATIONAHA.117.027828 1114. Lie OH, Rootwelt-Norberg C, Dejgaard LA, Leren IS, Stokke MK, Edvardsen T, et al. Prediction of life-threatening ventricular arrhythmia in patients with arrhythmogenic cardiomyopathy: a primary prevention cohort study. JACC Cardiovasc Imaging 2018; 11:1377–1386. https://doi.org/10.1016/j.jcmg.2018.05.017 1115. Costa S, Koch K, Gasperetti A, Akdis D, Brunckhorst C, Fu G, et al. Changes in exercise capacity and ventricular function in arrhythmogenic right ventricular cardiomyopathy: the impact of sports restriction during follow-up. J Clin Med 2022;11:1150. https://doi.org/10.3390/jcm11051150 1116. Sawant AC, Te Riele AS, Tichnell C, Murray B, Bhonsale A, Tandri H, et al. Safety of American Heart Association-recommended minimum exercise for desmosomal mutation carriers. Heart Rhythm 2016;13:199–207. https://doi.org/10.1016/j.hrthm. 2015.08.035 1117. Lie OH, Dejgaard LA, Saberniak J, Rootwelt C, Stokke MK, Edvardsen T, et al. Harmful effects of exercise intensity and exercise duration in patients with arrhythmogenic cardiomyopathy. JACC Clin Electrophysiol 2018;4:744–753. https://doi.org/10. 1016/j.jacep.2018.01.010 1118. Pelliccia A, Sharma S, Gati S, Back M, Borjesson M, Caselli S, et al. 2020 ESC Guidelines on sports cardiology and exercise in patients with cardiovascular disease. Eur Heart J 2021;42:17–96. https://doi.org/10.1093/eurheartj/ehaa605 1119. Cruz FM, Sanz-Rosa D, Roche-Molina M, Garcia-Prieto J, Garcia-Ruiz JM, Pizarro G, et al. Exercise triggers ARVC phenotype in mice expressing a disease-causing mutated version of human plakophilin-2. J Am Coll Cardiol 2015;65:1438–1450. https://doi.org/ 10.1016/j.jacc.2015.01.045 1120. Maron BJ, Haas TS, Murphy CJ, Ahluwalia A, Rutten-Ramos S. Incidence and causes of sudden death in U.S. college athletes. J Am Coll Cardiol 2014;63:1636–1643. https:// doi.org/10.1016/j.jacc.2014.01.041 1121. Malhotra A, Dhutia H, Finocchiaro G, Gati S, Beasley I, Clift P, et al. Outcomes of cardiac screening in adolescent soccer players. N Engl J Med 2018;379:524–534. https:// doi.org/10.1056/NEJMoa1714719 1122. Harmon KG, Drezner JA, Maleszewski JJ, Lopez-Anderson M, Owens D, Prutkin JM, et al. Pathogeneses of sudden cardiac death in national collegiate athletic association athletes. Circ Arrhythm Electrophysiol 2014;7:198–204. https://doi.org/10.1161/ CIRCEP.113.001376 1123. Skjolsvik ET, Hasselberg NE, Dejgaard LA, Lie OH, Andersen K, Holm T, et al. Exercise is associated with impaired left ventricular systolic function in patients with lamin A/C genotype. J Am Heart Assoc 2020;9:e012937. https://doi.org/10. 1161/JAHA.119.012937 1124. Dejgaard LA, Haland TF, Lie OH, Ribe M, Bjune T, Leren IS, et al. Vigorous exercise in patients with hypertrophic cardiomyopathy. Int J Cardiol 2018;250:157–163. https:// doi.org/10.1016/j.ijcard.2017.07.015 1125. Pelliccia A, Caselli S, Pelliccia M, Musumeci MB, Lemme E, Di Paolo FM, et al. Clinical outcomes in adult athletes with hypertrophic cardiomyopathy: a 7-year follow-up study. Br J Sports Med 2020;54:1008–1012. https://doi.org/10.1136/bjsports-2019- 100890 1126. Saarel EV, Law I, Berul CI, Ackerman MJ, Kanter RJ, Sanatani S, et al. Safety of sports for young patients with implantable cardioverter-defibrillators: long-term results of the multinational ICD sports registry. Circ Arrhythm Electrophysiol 2018;11: e006305. https://doi.org/10.1161/CIRCEP.118.006305 1127. Siu SC, Sermer M, Colman JM, Alvarez AN, Mercier LA, Morton BC, et al. Prospective multicenter study of pregnancy outcomes in women with heart disease. Circulation 2001;104:515–521. https://doi.org/10.1161/hc3001.093437 1128. Roos-Hesselink JW, Ruys TP, Stein JI, Thilén U, Webb GD, Niwa K, et al. Outcome of pregnancy in patients with structural or ischaemic heart disease: results of a registry of the European Society of Cardiology. Eur Heart J 2013;34:657–665. https://doi.org/ 10.1093/eurheartj/ehs270 1129. Linde C, Bongiorni MG, Birgersdotter-Green U, Curtis AB, Deisenhofer I, Furokawa T, et al. Sex differences in cardiac arrhythmia: a consensus document of the European Heart Rhythm Association, endorsed by the Heart Rhythm Society and Asia Pacific Heart Rhythm Society. Europace 2018;20:1565–1565ao. https://doi.org/10.1093/ europace/euy067 1130. Regitz-Zagrosek V, Roos-Hesselink JW, Bauersachs J, Blomström-Lundqvist C, Cífková R, De Bonis M, et al. 2018 ESC Guidelines for the management of cardiovascular diseases during pregnancy. Eur Heart J 2018;39:3165–3241. https://doi.org/10. 1093/eurheartj/ehy340 1131. Sliwa K, Mebazaa A, Hilfiker-Kleiner D, Petrie MC, Maggioni AP, Laroche C, et al. Clinical characteristics of patients from the worldwide registry on peripartum cardiomyopathy (PPCM): EURObservational Research Programme in conjunction with the Heart Failure Association of the European Society of Cardiology Study Group on PPCM. Eur J Heart Fail 2017;19:1131–1141. https://doi.org/10.1002/ejhf.780 1132. Lidegaard Ø, Løkkegaard E, Jensen A, Skovlund CW, Keiding N. Thrombotic stroke and myocardial infarction with hormonal contraception. N Engl J Med 2012;366: 2257–2266. https://doi.org/10.1056/NEJMoa1111840 1133. D’Souza R, Ostro J, Shah PS, Silversides CK, Malinowski A, Murphy KE, et al. Anticoagulation for pregnant women with mechanical heart valves: a systematic review and meta-analysis. Eur Heart J 2017;38:1509–1516. https://doi.org/10.1093/ eurheartj/ehx032 1134. Chan WS, Anand S, Ginsberg JS. Anticoagulation of pregnant women with mechanical heart valves: a systematic review of the literature. Arch Intern Med 2000;160: 191–196. https://doi.org/10.1001/archinte.160.2.191 1135. Priori SG, Blomstrom-Lundqvist C, Mazzanti A, Blom N, Borggrefe M, Camm J, et al. 2015 ESC Guidelines for the management of patients with ventricular arrhythmias and the prevention of sudden cardiac death: The Task Force for the Management of Patients with Ventricular Arrhythmias and the Prevention of Sudden Cardiac Death of the European Society of Cardiology (ESC). Endorsed by: Association for European Paediatric and Congenital Cardiology (AEPC). Eur Heart J 2015;36: 2793–2867. https://doi.org/10.1093/eurheartj/ehv316 1136. Miyoshi T, Kamiya CA, Katsuragi S, Ueda H, Kobayashi Y, Horiuchi C, et al. Safety and efficacy of implantable cardioverter-defibrillator during pregnancy and after delivery. Circ J 2013;77:1166–1170. https://doi.org/10.1253/circj.CJ-12-1275 1137. Krul SP, van der Smagt JJ, van den Berg MP, Sollie KM, Pieper PG, van Spaendonck-Zwarts KY. Systematic review of pregnancy in women with inherited Downloaded from academic.oup.com/eurheartj/article/44/37/3503/7246608 by guest on 07 October 2026